Tuberculosis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Future investigations== | ==Future investigations== | ||
In future therapies the following questions must be pondered on . | |||
1) How can we shorten chemotherapy? | |||
2)How can the interval between the therapy reduced ? | |||
3) How can new drugs be developed ? | |||
4) What is the best therapy for tuberculosis with HIV ? | |||
5) Role of immunomodulation | |||
==References== | ==References== |
Revision as of 21:47, 24 September 2014
Tuberculosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tuberculosis future or investigational therapies On the Web |
American Roentgen Ray Society Images of Tuberculosis future or investigational therapies |
Tuberculosis future or investigational therapies in the news |
Risk calculators and risk factors for Tuberculosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Future investigations
In future therapies the following questions must be pondered on .
1) How can we shorten chemotherapy?
2)How can the interval between the therapy reduced ?
3) How can new drugs be developed ?
4) What is the best therapy for tuberculosis with HIV ?
5) Role of immunomodulation